West Nile virus vaccines

Bibliography

• MURGUE B, ZELLER H, DEUBEL V: The ecology and epidemiology of West Nile virus in Africa, Europe and Asia. Curc Top. Microbial. Immunol (2002) 267:195–221.
   PubMed Web of Science ®Google Scholar
• PETERSEN LR, ROEHRIG JT: West Nile virus: a reemerging global pathogen. Emerg. Infect. Dis. (2001) 7(4):611–614.
   PubMed Web of Science ®Google Scholar
• •Comprehensive review of 1999 WNV outbreak in New York.
   Google Scholar
• MONATH TP: Prospects for development of a vaccine against the West Nile virus. Ann. NY Acad. Sci. (2001) 951:1–12.
   PubMed Web of Science ®Google Scholar
• ••Overview of the development of YFV-basedchimeric vaccines against JEV and WNV
   Google Scholar
• HEINZ FX, COLLETT MS, PURCELL RH et al: Family Flaviviridae. In: Virus Taxonomy 2' Report of the International Committee for the Taxonomy of Viruses. Van Regenmortel MH, Fauquet CM, Bishop DHL et al. (Eds), Academic Press, San Diego, USA (2000):859–878.
   Google Scholar
• HAYES C: West Nile fever. In: The Arboviruses: Epidemiology and Ecology (Vol. I Monath TP (Ed.), CRC Press, Boca Raton, Florida, USA (1988):59–88.
   Google Scholar
• HALL RA, BROOM AK, SMITH DW et al.: The ecology and epidemiology of Kunjin virus. In: Japanese Encephalitis and West Nile Viruses. Mackenzie JS, Barrett ADT, and Deubel V (Eds), Current Topics in Microbiology and Immunology (2002) 267: 253–269.
   Google Scholar
• ••Detailed review of KUNV ecology,epidemiology and its relationship to WNV
   Google Scholar
• ESTRADA-FRANCO JG, NAVARRO-LOPEZ R, BEASLEY DW et al.: West Nile virus in Mexico: evidence of widespread circulation since July 2002. Emerg. Infect. Dis. (2003) 9(12):1604–1607.
   PubMed Web of Science ®Google Scholar
• DUPUIS AP 2ND, MARRA PP, KRAMER LD: Serologic evidence of West Nile virus transmission, Jamaica, West Indies. Emerg. Infect. Dis. (2003) 9(7):860–863.
   PubMed Web of Science ®Google Scholar
• BRINTON MA: The molecular biology of West Nile virus: a new invader of the western hemisphere. Ann. Rev Microbiol (2002) 56:371–402.
   PubMed Web of Science ®Google Scholar
• WESTAWAY EG, MACKENZIE JM, KHROMYKH AA: Replication and gene function in Kunjin virus. Curc Top. Microbiol Immunol (2002) 267:323–351.
   PubMed Web of Science ®Google Scholar
• •Review of the flavivirus replication strategy elucidated from studies on KUNV
   Google Scholar
• WESTAWAY EG, MACKENZIE JM, KENNEY MT et al.: Ultrastructure of Kunjin virus-infected cells: colocalization of NS1 and NS3with double-stranded RNA, and of NS2B with N53, in virus-induced membrane structures. Virol (1997) 71(9):6650–6661.
   Web of Science ®Google Scholar
• MACKENZIE JM, KHROMYKH AA, JONES MK et al: Subcellular localization and some biochemical properties of the Flavivirus Kunjin nonstructural proteins NS2A and NS4A. Virology (1998) 245(2):203–215.
   PubMed Web of Science ®Google Scholar
• MACKENZIE JM, WESTAWAY EG: Assembly and maturation of the flavivirus Kunjin virus appear to occur in the rough endoplasmic reticulum and along the secretory pathway, respectively. J Virol (2001) 75(22):10787–10799.
   PubMed Web of Science ®Google Scholar
• STADLER K, ALLISON SL, SCHALICH Jet al.: Proteolytic activation of tick-borne encephalitis virus by furin. Vim/. (1997) 71(11):8475–8481.
   Google Scholar
• JOHNSTON LJ, HALLIDAY GM, KING NJ: Langerhans cells migrate to local lymph nodes following cutaneous infection with an arbovirus. J. Invest. Dermatol (2000) 114(3):560–568.
   PubMed Web of Science ®Google Scholar
• DIAMOND MS, SHRESTHA B, MEHLHOP E et al.: Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus. Viral Iminunol (2003) 16(3):259–278.
   PubMed Web of Science ®Google Scholar
• •Comprehensive review of recent studies on the immune responses to WNV.
   Google Scholar
• MONATH TP, HEINZ FX: Flaviviruses. In: Field's Virology Ord Edition). Fields BN, Knipe DM, Howley PM (Eds), Lippencott-Raven Publishers, Philadelphia, USA (1996):961–1034.
   Google Scholar
• SAMPSON BA, AMBROSI C, CHARLOT A et al.: The pathology of human West Nile virus infection. Hum. Pathol (2000) 31(5):527–531.
   PubMed Web of Science ®Google Scholar
• DIAMOND MS, SHRESTHA B, MARRI A et al.: B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus.Virol (2003) 77(4):2578–2586.
   Web of Science ®Google Scholar
• DIAMOND MS, SITATI EM, FRIEND LD et al.: A critical role for induced IgM in the protection against West Nile virus infection. Exp. Med. (2003) 198(12):1853–1862.
   PubMed Web of Science ®Google Scholar
• ROEHRIG JT: Antigenic structure of flavivirus proteins. Adv. Virus Res. (2003) 59:141–175.
   PubMed Web of Science ®Google Scholar
• HALL RA, BROOM AK, HARTNETT AC et al: Immunodominant epitopes on the NS1 protein of MVE and KUN viruses serve as targets for a blocking ELISA to detect virus-specific antibodies in sentinel animal serum. Vim] Methods. (1995) 51:201–210.
   PubMed Web of Science ®Google Scholar
• BLITVICH BJ, MARLENEE NL, HALL RA et al.: Epitope-blocking enzyme-linked immunosorbent assays for the detection of serum antibodies to West Nile virus in multiple avian species. Clin. Microbiol 41:1041-1047
   Google Scholar
• WONG SJ, BOYLE RH, DEMAREST VL et al.: Immunoassay targeting nonstructural protein 5 to differentiate West Nile virus infection from dengue and St. Louis encephalitis virus infections and from flavivirus vaccination. J. Clin. Microbiol (2003) 41(9):4217–4223.
   Google Scholar
• SCHLESINGER JJ, BRANDRISS MW, PUTNAK JR et al.: Cell surface expression of yellow fever virus non-structural glycoprotein NS1: consequences of interaction with antibody. Gen. Virol (1990) 71( 3):593–599.
   PubMedGoogle Scholar
• HENKART PA: Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity (1994) 1(5):343–346.
   PubMed Web of Science ®Google Scholar
• KAGI D, VIGNAUX F, LEDERMANN B: Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science (1994) 265(5171):528–530.
   PubMed Web of Science ®Google Scholar
• WANG Y, LOBIGS M, LEE E et al: CD8' T cells mediate recovery and immunopathology in West Nile virus encephalitis.Virol (2003) 77(24):13323–13334.
   Web of Science ®Google Scholar
• PARRISH CR, COIA G, HILL A et al: Preliminary analysis of murine cytotoxic T cell responses to the proteins of the flavivirus Kunjin using vaccinia virus expression. Gen. Vim] (1991) 72(7):1645–1653.
   PubMedGoogle Scholar
• •Evidence of CTL response to KUNV non-structural proteins.
   Google Scholar
• HILL AB, MULLBACHER A, PARRISH C et al: Broad cross-reactivity with marked fine specificity in the cytotoxic T cell response to flaviviruses. Gen. Vim] (1992) 73(5):1115–1123.
   PubMedGoogle Scholar
• ROTHMAN AL, KURANE I, LAI CJ et al: Dengue virus protein recognition by virus-specific murine CD8' cytotoxic T lymphocytes. Vim] (1993) 67(2):801–806.
   Google Scholar
• SPAULDING AC, KURANE I, ENNIS FA et al.: Analysis of murine CD8(+) T-cell clones specific for the Dengue virus N53 protein: flavivirus cross-reactivity and influence of infecting serotype. Vim] (1999)73(1):398–403.
   Google Scholar
• LOBIGS M, ARTHUR CE, MULLBACHER A et al.: The flavivirus nonstructural protein N53 is a dominant source of cytotoxic T cell peptide determinants. Virology. (1994) 202(1):195–201.
   PubMed Web of Science ®Google Scholar
• •Mapping of CTL responses to flavivirus NS3 protein.
   Google Scholar
• REGNER M, LOBIGS M, BLANDEN RV et al: Antiviral cytotoxic T cells cross-reactively recognize disparate peptide determinants from related viruses but ignore more similar self- and foreign determinants. Viral Immunol (2001)14:135–149.
   PubMedGoogle Scholar
• CO MD, TERAJIMA M, CRUZ J et al: Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on non-structural proteins NS1, N52b, N53, and the structural protein E. Virology (2002) 293(1):151–163.
   PubMed Web of Science ®Google Scholar
• TAKADA K, MASAKI H, KONISHI E et al.: Definition of an epitope on Japanese encephalitis virus (JEV) envelope protein recognized by JEV-specific murine CD8' cytotoxic T lymphocytes. Arch. Vim] (2000) 145(3):523–534.
   PubMed Web of Science ®Google Scholar
• YANG JS, KIM JJ, HWANG D et al.: Induction of potent Thl-type immune responses from a novel DNA vaccine for West Nile virus New York isolate (WNY-NY1999). J. Infect. Dis. (2001) 184:809–816.
   PubMed Web of Science ®Google Scholar
• BARRETT AD: Current status of flavivirusvaccines. Ann. NY Acad. Sci (2001) 951:262–271.
   PubMed Web of Science ®Google Scholar
• GALLER R, PUGACHEV KV, SANTOS CL et al.: Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil. Vim] (2001) 290(2):309–319.
   Google Scholar
• MONATH TP: Japanese encephalitis vaccines: current vaccines and future prospects. Carr: Top. Microbiol Immunol (2002) 267:105–138.
   PubMed Web of Science ®Google Scholar
• BISTA MB, BANERJEE MK, SHIN SH et al: Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study. Lancet (2001) 358(9284):791–795.
   PubMed Web of Science ®Google Scholar
• BARRETT PN, SCHOBER-BENDIXEN S, EHRLICH HJ: History of TBE vaccines. Vaccine (2003) 21 (Suppl. 1):541–549.
   Google Scholar
• NG T, HATHAWAY D, JENNINGS N et al.: Equine vaccine for West Nile virus. Dev. Biol. Basel. (2003)114:221–227.
   PubMedGoogle Scholar
• •Development of the first WNV vaccine licensed for horses.
   Google Scholar
• KAHLER SC: APHIS: West Nile virus vaccine safe for use. J. Am. Vet. Med. Assoc. (2003) 223(4):416–418.
   PubMed Web of Science ®Google Scholar
• NUSBAUM KE, WRIGHT JC, JOHNSTON WB et al.: Absence of humoral response in flamingos and red-tailed hawks to experimental vaccination with a killed West Nile virus vaccine. Avian Dis. (2003)47(3):750–752.
   PubMed Web of Science ®Google Scholar
• TESH RB, ARROYO J, TRAVASSOS DA ROSA AP et al.: Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model. Emerg. Infect. Dis. (2002) 8(12):1392–1397.
   Google Scholar
• •Comparative protective efficacy of killed and chimeric vaccines against WNV in hamsters.
   Google Scholar
• MALKINSON M, BANET C, KHINICH Y et al.: Use of live and inactivated vaccines in the control of West Nile fever in domestic geese. Ann. NY Acad. Sci (2001) 951:255–261.
   PubMed Web of Science ®Google Scholar
• LIEBERMAN M, TESH R, CLEMENTS D et al: A recombinant subunit West Nile vaccine protects against fatal West Nile encephalitis in hamsters. Proceedings of the Viral Vaccine Meeting, Barcelona, Spain (2003).
   Google Scholar
• WANG T, ANDERSON JF, MAGNARELLI LA et al.: Immunization of mice against West Nile virus with recombinant envelope protein. Immunol (2001) 167(9):5273–5277.
   Web of Science ®Google Scholar
• ULMER JB, DONNELLY JJ, PARKER SEet al.: Heterologous protection against influenza by injection of DNA encoding a viral protein. Science (1993) 259(5102):1745–1749.
   Google Scholar
• PHILLPOTTS RJ, VENUGOPAL K, BROOKS T: Immunisation with DNA polynucleotides protects mice against lethal challenge with St. Louis encephalitis virus. Arch. Virol (1996) 141(3–4)743–749.
   Google Scholar
• SCHMALJOHN C, VANDERZANDEN L, BRAY M et al: Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge. J. Vim]. (1997) 71:9563–9569.
   Web of Science ®Google Scholar
• COLOMBAGE G, HALL RA, PAVY M et al: DNA-based and alphavirus-vectored immunisation with PrM and E proteins elicits long-lived and protective immunity against the Flavivirus, Murray Valley encephalitis virus. Virology (1998) 250:151–163.
   PubMed Web of Science ®Google Scholar
• CHANG GJ, HUNT AR, DAVIS BS: A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice.Vim/. (2000)74(9):4244–4252.
   Web of Science ®Google Scholar
• CHANG GJ, DAVIS BS, HUNT AR et al.: Flavivirus DNA vaccines: current status and potential. Ann. NY Acad. Sci. (2001) 951:272–285.
   PubMed Web of Science ®Google Scholar
• DAVIS HL: CpG motifs for optimizationof DNA vaccines. Dev. Biol. Basel (2000) 104:165–169.
   PubMedGoogle Scholar
• DAVIS BS, CHANG GJ, CROPP B et al:West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses M vitro a non-infectious recombinant antigen that can be used in enzyme-linked immunosorbent assays. J. Vim]. (2001) 75(9):4040–4047.
   Web of Science ®Google Scholar
• ••Demonstration that WNV prM-E DNAvaccine protects horses and mice.
   Google Scholar
• LEE TP, COONAN KM, HEDSTROM RC: Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers. Vaccine (2000) 18(18):1893–1901.
   PubMed Web of Science ®Google Scholar
• LEDWITH BJ, MANAM S, TROILO PJ et al.: Plasmid DNA vaccines: assay for integration into host genomic DNA. Dev. Biol. Basel. (2000) 104:33–43.
   PubMedGoogle Scholar
• MONATH TP, ARROYO J, MILLER C et al.: West Nile virus vaccine. Curc Drug Targets Infect. Disord. (2001) 1:37–50.
   PubMedGoogle Scholar
• PRICE WH, LEE RW, GUNKEL WF et al.: The virulence of West Nile virus and TP21 virus and their application to a Group B arbor virus vaccine. Am. .1. Bop. Med. Hyg. (1961) 8:403–422.
   Google Scholar
• LUSTIG S, OLSHEVSKY U, BEN-NATHAN D et al: A live attenuated West Nile virus strain as a potential veterinary vaccine. Viral Immunol (2000) 13(4):401–410.
   PubMed Web of Science ®Google Scholar
• CHAMBERS TJ, NESTOROWICZ A, MASON PW et al.: Yellow fever/Japanese encephalitis chimeric viruses:construction and biological properties. 1 Virol (1999) 73(4):3095–3101.
   Google Scholar
• LANGE VIN SA, ARROYO J, MONATH TP et al.: Host-range restriction of chimeric yellow fever-West Nile vaccine in fish crows (Corvus ossifragus). Am. j Bop. Med. Hyg. (2003) 69(1):78–80.
   PubMed Web of Science ®Google Scholar
• JOHNSON BW, CHAMBERS TV, CRABTREE MB et al: Growth characteristics of the veterinary vaccine candidate ChimeriVax-West Nile (WN) virus in Aedes and Culex mosquitoes. Med. Vet. Entomol (2003) 17(3):235–243.
   PubMed Web of Science ®Google Scholar
• PLETNEV AG, CLAIRE MS, ELKINS R et al.: Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus. Virology (2003)314(1):190–195.
   PubMed Web of Science ®Google Scholar
• •An attenuated WNV/DENV chimeric vaccine protects primates from WNV challenge.
   Google Scholar
• MONATH TP, GUIRAKHOO F, NICHOLS R et al: Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): Phase II clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen. J. Infect. Dis. (2003) 188(8):1213–1230.
   PubMed Web of Science ®Google Scholar
• DE MADRID AT, PORTERFIELD JS: The flaviviruses (group B arboviruses): a cross-neutralization study. J. Gen. Virol (1974) 23:91–96.
   PubMed Web of Science ®Google Scholar
• CALISHER CH, KARABATSOS N, DALRYMPLE JM et al.: Antigenetic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. J. Gen. Viral. (1989) 70:37–43.
   PubMed Web of Science ®Google Scholar
• GOULD EA, BUCKLEY A, CAMMACK N et al: Examination of the immunological relationships between flaviviruses using yellow fever virus monoclonal antibodies. J. Gen. Vim]. (1985) 66(7):1369–1382.
   PubMedGoogle Scholar
• PRICE WH, THIND IS: Protection against West Nile virus induced by a previous injection with dengue virus. Am. Epidemiol (1971) 94(6):596–607.
   PubMed Web of Science ®Google Scholar
• GOVERDHAN MK, KULKARNI AB, GUPTA AK et al: Two-way cross-protection between West Nile and Japanese encephalitis viruses in bonnet macaques. Acta Virol (1992) 36(3):277–283.
   PubMed Web of Science ®Google Scholar
• KANESA-THASAN N, PUTNAK JR, MANGIAFICO JA et al.: Short report: absence of protective neutralizing antibodies to West Nile virus in subjects following vaccination with Japanese encephalitis or dengue vaccines. Am. I Bop. Med. Hyg. (2002) 66(2):115–116.
   PubMed Web of Science ®Google Scholar
• TAKASAKI T, YABE S, NEROME R et al.: Partial protective effect of inactivated Japanese encephalitis vaccine on lethal West Nile virus infection in mice. Vaccine (2003) 21(31):4514–4518.
   PubMed Web of Science ®Google Scholar
• HALSTEAD SB: Pathogenesis of dengue: challenges to molecular biology. Science (1988) 239(4839):476–481.
   PubMed Web of Science ®Google Scholar
• MONGKOLSAPAYA J, DEJNIRATTISAI W, XU XN et al: Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat. Med. (2003) 9(7):921–927.
   PubMed Web of Science ®Google Scholar
• •Evidence that cell-mediated immune responses to one flavivirus may exacerbate subsequent infections with a related virus.
   Google Scholar
• BROOM AK, WALLACE M, MACKENZIE JS et al.: Immunisation with gamma globulin to Murray Valley encephalitis virus and with an inactivated
   Google Scholar
• Japanese encephalitis virus vaccine as a prophylaxis against Australian encephalitis: evaluation in a mouse model.," Med. Virol (2000) 61:259-265. Report that antibody induced to a killed JEV vaccine may enhance disease caused by infection with MVEV in mice.
   Google Scholar
• LOBIGS M, PAVY M, HALL R: Cross- protective and infection-enhancing immunity in mice vaccinated against flaviviruses belonging to the Japanese encephalitis virus serocomplex. Vaccine (2003) 21(15):1572–1579.
   PubMed Web of Science ®Google Scholar
• •Immunisation of mice with a killed MVEV vaccine enhances subsequent infection with JEV.
   Google Scholar
• HALL RA: The emergence of West Nile virus: the Australian connection. Viral Inonunol. (2000) 13(4):447–461.
   PubMed Web of Science ®Google Scholar
• LANCIOTTI RS, EBEL GD, DEUBEL V et al.: Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East. Virology (2002) 298(1):96–105.
   PubMed Web of Science ®Google Scholar
• •Comprehensive genetic analysis of WNV and KUNV strains from different regions of the world.
   Google Scholar
• WESTAWAY EG, BRINTON MA, GAIDAMOVICH SY et al: Flaviviridae. Intervirology (1985) 24(4):183–192.
   PubMed Web of Science ®Google Scholar
• HALL RA, KHROMYKH AA, MACKENZIE JM et at.: Loss of dimerisation of the nonstructural protein NS1 of Kunjin virus delays viral replication and reduces virulence in mice, but still allows secretion of NS1. Virology (1999) 264(1):66–75.
   Google Scholar
• •Novel mutation of a conserved residue in KUNV NS1 protein results in a stable attenuated virus.
   Google Scholar
• HALL RA, NISBET DJ, PHAM KB et al: DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus. Proc. Natl. Acad. Sd. USA (2003) 100:10460–10464.
   PubMed Web of Science ®Google Scholar
• ••A novel DNA vaccine coding forlive attenuated KUNV protects mice against WNV.
   Google Scholar
• KHROMYKH AA, VARNAVSKI AN, SEDLAK PL et al.: Coupling between replication and packaging of flavivirus RNA: evidence derived from the use of DNA-based full-length cDNA clones of Kunjin virus., " Vim/. (2001) 75(10):4633–4640.
   Google Scholar
• TURELL MJ, BUNNING M, LUDWIG GV et al.: DNA vaccine for West Nile virus infection in fish crows (Corvus ossifragus). Einerg. Infect. Dis. (2003) 9(9):1077–1081.
   PubMed Web of Science ®Google Scholar
• http://www.cdc.gov/ncidod/dvbid/westnile/ surv&control.htm CDC Statistics, Surveillance and Control.
   Google Scholar
• http://www.cdc.gov/ncidod/dvbid/westnile/ surv&contro103Maps.htm CDC Statistics, Surveillance and Control, map of cases of infection.
   Google Scholar
• http://dsol-smed.hc-sc.gc.ca/wnv/ map600_e.phtml Health Canada, WNV surveillance information.
   Google Scholar
• http://www.bridleandbit.com/artman/ publish/article_2815.shtml Bridle & Bit, horse health.
   Google Scholar